Macquarie Group’s Dare Bioscience DARE Stock Holding History

Macquarie Group’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-575	Closed	-$5K	–	1738
2018 Q4	$5K	Buy	+575	New	+$6.06K	﹤0.01%	2096

Other funds holding DARE

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Macquarie Group's DARE Position: Q1 2019 in Review

Macquarie Group sold out of Dare Bioscience (DARE) in Q1 2019, closing a stake of 575 shares — an estimated $5K sold.

Macquarie Group first reported a position in DARE in Q4 2018 and held it in 1 quarter. The position peaked at $5K in Q4 2018. 14 funds tracked by Wall St. Rank hold DARE as of Q1 2019.

Macquarie Group reported no remaining Dare Bioscience position as of Q1 2019 after selling out during the quarter.
Macquarie Group sold 575 Dare Bioscience shares in Q1 2019, an estimated $5K.
Macquarie Group first reported a position in Dare Bioscience in Q4 2018 and held it in 1 quarter.
Macquarie Group's Dare Bioscience position peaked at $5K in Q4 2018.
14 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2019.

Based on Macquarie Group's 13F filing for Q1 2019, filed 15 May 2019.